MANKIND

Mankind Pharma Ltd’s current Sell rating reflects a comprehensive analysis of its operational quality, valuation, financial trends, and technical outlook as of 07 February 2026. The rating, last updated on 19 Nov 2025, remains relevant given the company’s recent performance and market conditions. Investors are advised to interpret this rating as a signal to exercise caution and to evaluate the stock carefully within the context of their investment objectives and risk tolerance.